NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) today reported worldwide sales of $3,978 million in fourth quarter 2010, down 2.5% versus fourth quarter 2009. Global unit volume grew 1.0%, pricing was flat with the year ago quarter and foreign exchange was negative 3.5%. Organic sales (excluding foreign exchange, acquisitions and divestments) grew 1.0%.
Net income and diluted earnings per share in fourth quarter 2010 were $624 million and $1.24, respectively. Net income and diluted earnings per share in fourth quarter 2009 were $631 million and $1.21, respectively.
Net income in the quarter included $61 million of aftertax charges ($0.12 per diluted share) for termination benefits relating to ongoing overhead reduction initiatives. These initiatives were funded by a $30 million aftertax gain ($0.06 per diluted share) from the sale of non-core product lines and a benefit of $31 million ($0.06 per diluted share) resulting from a non-recurring tax initiative relating to an overseas subsidiary. Excluding these items, net income was $624 million, a decrease of 1% versus fourth quarter 2009 and diluted earnings per share was $1.24, an increase of 2% versus fourth quarter 2009.
The currency devaluation in Venezuela announced in December 2010 resulted in a $36 million reduction in operating profit from remeasuring the Venezuelan balance sheet, which was completely offset by $38 million of related tax benefits.
Gross profit margin was 59.1%, down 40 basis points versus the year ago quarter’s record level, due to the impact of negative foreign exchange, higher material costs and increased promotional investments more than offsetting benefits from cost-saving initiatives.
Selling, general and administrative expenses increased by 40 basis points to 34.6% of net sales in fourth quarter 2010 from 34.2% in fourth quarter 2009, as worldwide advertising spending increased 3% versus the year ago quarter to $406 million. Advertising as a percent to sales increased 50 basis points to 10.2% from 9.7% in fourth quarter 2009.
Operating profit decreased 9% to $905 million in fourth quarter 2010. Excluding the above-mentioned charges related to termination benefits and the gain on sale of non-core product lines, operating profit decreased 5% to $941 million compared to a record $991 million in fourth quarter 2009, decreasing as a percent to sales from 24.3% to 23.7%.
The effective tax rate was 26.8% in fourth quarter 2010, which was impacted by the currency devaluation in Venezuela as well as the other items noted above. Excluding these items, the effective tax rate was 32.5% in the quarter.
Net cash provided by operations in 2010 decreased by 2% to $3,211 million versus a very strong 42% increase in 2009. Working capital as a percentage of sales increased 70 basis points to 0.3%. Free cash flow before dividends remains very strong, once again exceeding 100% of net income.
For the full year 2010, worldwide sales were $15,564 million, up 1.5% versus full year 2009. Global unit volume grew 3.0%, pricing was flat with the year ago period and foreign exchange was negative 1.5%. Organic sales (excluding foreign exchange, acquisitions and divestments) grew 3.0%.
Net income and diluted earnings per share for full year 2010 were $2,203 million and $4.31, respectively, compared to $2,291 million and $4.37, respectively, in 2009. As previously disclosed, full year 2010 results were reduced by a one-time, non-cash aftertax charge of $271 million ($0.53 per diluted share) resulting from a required accounting change related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. Full year 2010 results also include $61 million of aftertax charges ($0.12 per diluted share) for termination benefits relating to ongoing overhead reduction initiatives, a $30 million aftertax gain ($0.06 per diluted share) from the sale of non-core product lines and a benefit of $31 million ($0.06 per diluted share) resulting from a non-recurring tax initiative relating to an overseas subsidiary. Excluding these items, net income was $2,474 million and diluted earnings per share was $4.84, increases of 8% and 11%, respectively, versus full year 2009.
Ian Cook, Chairman, President and Chief Executive Officer commented on the results and outlook excluding the previously announced first quarter 2010 one-time charge related to the transition to hyperinflationary accounting in Venezuela and the fourth quarter items noted above, “We are pleased to have achieved another year of double-digit earnings per share growth in 2010, despite aggressive competitive activity and difficult economic conditions around the world.
“Colgate’s global market shares in toothpaste and manual toothbrushes are both at record highs year to date. Colgate’s share of the global toothpaste market strengthened to 44.2% year to date, led by share gains in Brazil, China, India, Venezuela, France, Greece and the United Kingdom. Colgate also strengthened its global leadership in manual toothbrushes, with its global market share in that category reaching 31.6% year to date, up 1.6 share points versus year ago.
“Pleasingly, our leadership in emerging markets, which represent over half of our global sales, continued to strengthen during the quarter.
“As we enter 2011, we continue to plan for higher levels of advertising spending in support of a very full pipeline of new products, which should fuel top-line growth worldwide. We expect our sharp focus on cost-saving initiatives to deliver another year of gross margin expansion and we anticipate mid-single digit earnings per share growth for the year.”
At 11:00 a.m. ET today, Colgate will host a conference call to elaborate on fourth quarter results. To access this call as a webcast, please go to Colgate’s web site at http://www.colgate.com.
The following are comments about divisional performance. See attached Geographic Sales Analysis and Segment Information schedules for additional information on divisional sales and operating profit.
North America (18% of Company Sales)
North America sales declined 2.0% in the fourth quarter. Unit volume increased 1.5% with 4.0% lower pricing and 0.5% positive foreign exchange. Organic sales declined 2.5% during the quarter. North America operating profit decreased 8% during the quarter driven by increased promotional investments and higher material costs, partially offset by cost-saving initiatives.
In the U.S., new product launches including Colgate Triple Action and Colgate Sensitive MultiProtection toothpastes and the relaunch of Colgate Total toothpaste are contributing to strength in oral care. Colgate’s share of the manual toothbrush market is at 33.4% year to date, up 1.3 share points versus year ago, including Colgate Wisp mini-brush whose market share is at 4.9% year to date. Colgate 360° ActiFlex, Colgate Max White and Colgate Extra Clean manual toothbrushes contributed to the share gains.
Successful new products in the U.S. in other categories include Softsoap Body Butter Mega Moisture and Irish Spring Intensify body washes, Speed Stick Stainguard deodorant and Fabuloso Aroma Sensations liquid cleaner.
Looking ahead in the U.S., a full pipeline of new product launches is planned for 2011 supported by higher commercial investment. New introductions reaching store shelves in the first quarter include Colgate Total Gum Defense and Colgate MaxClean SmartFoam toothpastes, Colgate 360° Surround and Colgate Triple Action manual toothbrushes, Softsoap Body Butter Strawberry Smoother body wash, Palmolive Soft Touch dish liquid, Palmolive Baby bottle, toy and dish wash, Softsoap Pampered Hands foaming liquid hand soap and a new line of Irish Spring deodorants and antiperspirants.
Latin America (29% of Company Sales)
Latin America sales declined 7.5% during the quarter with unit volume declining 1.5%. Volume gains achieved in Mexico, Ecuador, Dominican Republic and Central America were more than offset by volume declines in Brazil and Venezuela. Higher pricing added 5.0% and foreign exchange was negative 11.0%. Organic sales for Latin America increased 3.5% during the quarter. Latin America operating profit decreased 14% during the quarter due to increased advertising and promotional investments and the impact of foreign exchange, especially in Venezuela. As a result of the currency devaluation in Venezuela noted above, operating profit for fourth quarter 2010 includes a charge of $36 million related to the remeasurement of the Venezuelan balance sheet.
Colgate’s strong leadership in oral care throughout Latin America continues, driven by market share gains in nearly every country. In Brazil, for example, Colgate’s toothpaste market share reached 70.6% year to date, up 50 basis points versus year ago. Strong sales of Colgate Sensitive Pro-Relief and Colgate Total toothpaste drove share gains throughout the region. Colgate’s leadership of the manual toothbrush market in the region also continues, driven by strong sales of Colgate 360° ActiFlex, Colgate Twister and Colgate Zig Zag manual toothbrushes. In mouthwash, market share gains were driven by Colgate Plax Whitening Tartar Control and Colgate Plax Complete Care mouthwashes.
Products in other categories contributing to market share gains included Palmolive Naturals Yogurt and Almond Oil and Palmolive Naturals Perfect Tone bar soaps, Lady Speed Stick Waterproof and Speed Stick Extreme deodorants and Protex Propolis bar soap.
Europe/South Pacific (20% of Company Sales)
Europe/South Pacific sales decreased 7.0% during the quarter. Unit volume was flat with the year ago quarter, pricing decreased 3.0% and foreign exchange was negative 4.0%. Volume gains in the GABA business, the United Kingdom, Germany, Denmark and Australia were offset by volume declines in France, Portugal and Romania. Organic sales for Europe/South Pacific declined 3.0%. Operating profit for the region decreased 19% during the quarter primarily due to the negative impact of foreign exchange, increased promotional investments and higher material costs, partially offset by the benefits from cost-saving initiatives.
Colgate strengthened its oral care leadership in the Europe/South Pacific region with toothpaste share gains in France, Italy, Portugal, Greece, the United Kingdom, Spain, Ireland, Norway, Sweden and Denmark. Successful premium products driving share gains include Colgate Sensitive Pro-Relief, Colgate Sensitive Pro-Relief Whitening, elmex Sensitive Professional and Colgate Max White One toothpastes. In the manual toothbrush category, Colgate 360° ActiFlex toothbrush contributed to share gains in key countries throughout the region.
Recent premium innovations contributing to strength in other product categories include Colgate 360° ActiFlex Sonic Power battery powered toothbrush, Colgate Plax Ice mouth rinse, Palmolive Nutra-Fruit shower crème and the Natura Verde line of home care products made with ingredients of natural origin and biodegradable formulas in recyclable bottles.
Greater Asia/Africa (19% of Company Sales)
Greater Asia/Africa sales and unit volume increased 11.0% and 9.0%, respectively, during the quarter. Volume gains were led by India, the Greater China region, Philippines, Turkey and South Africa. Pricing decreased 1.0% and foreign exchange was positive 3.0%. Organic sales for Greater Asia/Africa increased 8.0%. Operating profit for the region increased 11% during the quarter as higher sales and cost-saving initiatives more than offset higher material costs and increased advertising spending.
Colgate strengthened its toothpaste leadership in Greater Asia with market share gains in key countries throughout the region including India, China, Philippines, Thailand, Malaysia, Singapore, Taiwan and Ukraine. In India, for example, Colgate’s toothpaste market share reached a record 51.5% year to date, up 120 basis points versus year ago. Successful new products including Colgate Sensitive Pro-Relief, Colgate Sensitive Pro-Relief Whitening and Colgate Herbal Salt toothpastes and the relaunch of Colgate Total toothpaste drove share gains throughout the region.
Successful products contributing to growth in other categories in the region include Colgate 360° ActiFlex, Colgate Massager and Colgate Twister Gum Care manual toothbrushes, Colgate Plax Complete Care mouthwash and Lady Speed Stick Breathing Skin and Mennen Speed Stick Breathe and Protect deodorants.
Hill’s (14% of Company Sales)
Hill’s sales declined 2.0% during the quarter. Unit volume decreased 1.0%, pricing decreased 1.0% and foreign exchange was even with the year ago quarter. Volume declined in Russia, Germany and the United Kingdom, while volume gains were achieved in Canada, Italy and Brazil. In the U.S., volume was flat with the year ago period, the best volume performance since fourth quarter 2008. Hill’s organic sales declined 2.0% during the quarter. Operating profit decreased 1% during the quarter due to lower sales, higher advertising and higher material costs partially offset by benefits from cost-saving initiatives.
Recent new product introductions succeeding in the U.S. include Science Diet Small and Toy Breed Canine, Science Diet Healthy Mobility Canine, Science Diet Weight Loss System and Prescription Diet Therapeutic Weight Reduction Program.
New pet food products contributing to international sales include Science Diet Small and Toy Breed Canine, Science Diet Senior Advanced Canine and Feline, Science Plan Sterilized Cat and Science Plan VetEssentials Canine and Feline, a range of veterinary exclusive products addressing the top five essential health needs of pets.
***
About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Elmex, Tom’s of Maine, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. For more information about Colgate’s global business, visit the Company’s web site at http://www.colgate.com.
The Company’s annual meeting of shareholders is currently scheduled for Friday, May 6, 2011.
Substantially all market share data included in this press release is compiled from data as measured by ACNielsen.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast (other than historical information) may contain forward-looking statements. Such statements may relate, for example, to sales or unit volume growth, organic sales growth, profit and profit margin growth, earnings growth, financial goals, the impact of currency devaluations or exchange controls in Venezuela, cost-reduction plans, tax rates, new product introductions and commercial investment levels. These statements are made on the basis of our views and assumptions as of this time and we undertake no obligation to update these statements. We caution investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Investors should consult the Company’s filings with the Securities and Exchange Commission (including the information set forth under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009) for information about certain factors that could cause such differences. Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or the Company’s web site at http://www.colgate.com.
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
To supplement Colgate’s condensed income statements presented in accordance with accounting principles generally accepted in the United States of America (GAAP), the Company has disclosed non-GAAP measures of operating results that exclude certain items. Operating profit, operating profit margin, effective tax rate, net income and earnings per share are discussed both as reported (on a GAAP basis) and excluding the impact of the one-time charge related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010 and the fourth quarter 2010 items noted above. Management believes these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying business trends and performance of the Company’s ongoing operations and are useful for period-over-period comparisons of such operations. See “Non-GAAP Reconciliation” and “Non-GAAP Effective Tax Rate Reconciliation” for the three and twelve months ended December 31, 2010 and 2009 included with this release for a reconciliation of these financial measures to the related GAAP measures.
This release discusses organic sales growth, which excludes the impact of foreign exchange, acquisitions and divestments. Management believes this measure provides investors with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis, Percentage Changes – Fourth Quarter 2010 vs. 2009” for a comparison of organic sales growth to sales growth in accordance with GAAP.
The Company uses these financial measures internally in its budgeting process and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as net cash provided by operations less capital expenditures. As management uses this measure to evaluate the Company’s ability to satisfy current and future obligations, repurchase stock, pay dividends and fund future business opportunities, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. Free cash flow before dividends is not a GAAP measurement and may not be comparable to similarly titled measures reported by other companies. See “Condensed Consolidated Statements of Cash Flows For the Twelve Months Ended December 31, 2010 and 2009” for a comparison of free cash flow before dividends to net cash provided by operations as reported in accordance with GAAP.
(See attached tables for fourth quarter results.)
|
Table 1 |
|||||||||
| Colgate-Palmolive Company | |||||||||
| Consolidated Income Statements | |||||||||
| For the Three Months Ended December 31, 2010 and 2009 | |||||||||
| (in Millions Except Per Share Amounts) (Unaudited) | |||||||||
| 2010 | 2009 | ||||||||
| Net sales | $ | 3,978 | $ | 4,081 | |||||
| Cost of sales | 1,628 | 1,654 | |||||||
| Gross profit | 2,350 | 2,427 | |||||||
| Gross profit margin | 59.1 | % | 59.5 | % | |||||
| Selling, general and administrative expenses | 1,376 | 1,397 | |||||||
| Other (income) expense, net | 69 | 39 | |||||||
| Operating profit | 905 | 991 | |||||||
| Operating profit margin | 22.8 | % | 24.3 | % | |||||
| Interest expense, net | 16 | 18 | |||||||
| Income before income taxes | 889 | 973 | |||||||
| Provision for income taxes | 238 | 317 | |||||||
| Effective tax rate | 26.8 | % | 32.6 | % | |||||
| Net income including noncontrolling interests | 651 | 656 | |||||||
| Less: Net income attributable to noncontrolling interests | 27 | 25 | |||||||
| Net income attributable to Colgate-Palmolive Company | $ | 624 | $ | 631 | |||||
| Earnings per common share | |||||||||
| Basic | $ | 1.28 | $ | 1.25 | |||||
| Diluted | $ | 1.24 | $ | 1.21 | |||||
| Average common shares outstanding | |||||||||
| Basic | 481.7 | 497.4 | |||||||
| Diluted | 503.1 | 523.3 | |||||||
|
Table 2 |
|||||||||
| Colgate-Palmolive Company | |||||||||
| Consolidated Income Statements | |||||||||
| For the Twelve Months Ended December 31, 2010 and 2009 | |||||||||
| (in Millions Except Per Share Amounts) (Unaudited) | |||||||||
| 2010 | 2009 | ||||||||
| Net sales | $ | 15,564 | $ | 15,327 | |||||
| Cost of sales | 6,360 | 6,319 | |||||||
| Gross profit | 9,204 | 9,008 | |||||||
| Gross profit margin | 59.1 | % | 58.8 | % | |||||
| Selling, general and administrative expenses | 5,414 | 5,282 | |||||||
| Other (income) expense, net | 301 | 111 | |||||||
| Operating profit | 3,489 | 3,615 | |||||||
| Operating profit margin | 22.4 | % | 23.6 | % | |||||
| Interest expense, net | 59 | 77 | |||||||
| Income before income taxes | 3,430 | 3,538 | |||||||
| Provision for income taxes | 1,117 | 1,141 | |||||||
| Effective tax rate | 32.6 | % | 32.2 | % | |||||
| Net income including noncontrolling interests | 2,313 | 2,397 | |||||||
| Less: Net income attributable to noncontrolling interests | 110 | 106 | |||||||
| Net income attributable to Colgate-Palmolive Company | $ | 2,203 | $ | 2,291 | |||||
| Earnings per common share | |||||||||
| Basic | $ | 4.45 | $ | 4.53 | |||||
| Diluted | $ | 4.31 | $ | 4.37 | |||||
| Average common shares outstanding | |||||||||
| Basic | 487.8 | 499.5 | |||||||
| Diluted | 510.9 | 524.6 | |||||||
|
Table 3 |
||||||||||||||||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||||||
| Non-GAAP Reconciliation | ||||||||||||||||||||||||
| For the Three Months Ended December 31, 2010 and 2009 | ||||||||||||||||||||||||
| (in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||||||||||||
| 2010 | 2009 | |||||||||||||||||||||||
|
As Reported 1 |
Termination benefits |
Gain on sale of non-core product lines |
Tax initiatives |
As Adjusted Non-GAAP 1 |
As Reported |
|||||||||||||||||||
| Other (income) expense, net | $ | 69 | $ | 86 | $ | (50 | ) | $ | - | $ | 33 | $ | 39 | |||||||||||
| Operating profit | 905 | (86 | ) | 50 | - | 941 | 991 | |||||||||||||||||
| Operating profit margin | 22.8 | % | 23.7 | % | 24.3 | % | ||||||||||||||||||
| Income before income taxes | 889 | (86 | ) | 50 | - | 925 | 973 | |||||||||||||||||
| Provision for income taxes | 238 | (25 | ) | 20 | (31 | ) | 274 | 317 | ||||||||||||||||
| Net income including noncontrolling interests | 651 | (61 | ) | 30 | 31 | 651 | 656 | |||||||||||||||||
| Net income attributable to Colgate-Palmolive Company | $ | 624 | $ | (61 | ) | $ | 30 | $ | 31 | $ | 624 | $ | 631 | |||||||||||
|
Earnings per common share 2 |
||||||||||||||||||||||||
| Basic | $ | 1.28 | $ | (0.13 | ) | $ | 0.06 | $ | 0.06 | $ | 1.28 | $ | 1.25 | |||||||||||
| Diluted | $ | 1.24 | $ | (0.12 | ) | $ | 0.06 | $ | 0.06 | $ | 1.24 | $ | 1.21 | |||||||||||
| 1 |
Includes a $36 pretax loss ($2 aftertax gain) related to the remeasurement of the Venezuelan balance sheet and lower taxes on accrued but unpaid remittances resulting from the currency devaluation announced in December 2010. |
|
| 2 |
Basic and diluted earnings per share are computed independently for each quarter and the year to date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for the year to date period. In addition, the cumulative impact of Non-GAAP adjustments on the basic and diluted earnings per share may not necessarily equal the difference between "As Reported" and "As Adjusted Non-GAAP" as a result of rounding. |
|
|
|
|
Table 4 |
||||||||||||||||||||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||||||||||
| Non-GAAP Reconciliation | ||||||||||||||||||||||||||||
| For the Twelve Months Ended December 31, 2010 and 2009 | ||||||||||||||||||||||||||||
| (in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||||||||||||||||
| 2010 | 2009 | |||||||||||||||||||||||||||
|
As Reported 1 |
Venezuela Hyperinflationary 2 |
Termination benefits |
Gain on sale of non-core product lines |
Tax initiatives |
As Adjusted Non-GAAP 1 |
As Reported |
||||||||||||||||||||||
| Other (income) expense, net | $ | 301 | $ | 271 | $ | 86 | $ | (50 | ) | $ | - | $ | (6 | ) | $ | 111 | ||||||||||||
| Operating profit | 3,489 | (271 | ) | (86 | ) | 50 | - | 3,796 | 3,615 | |||||||||||||||||||
| Operating profit margin | 22.4 | % | 24.4 | % | 23.6 | % | ||||||||||||||||||||||
| Income before income taxes | 3,430 | (271 | ) | (86 | ) | 50 | - | 3,737 | 3,538 | |||||||||||||||||||
| Provision for income taxes | 1,117 | - | (25 | ) | 20 | (31 | ) | 1,153 | 1,141 | |||||||||||||||||||
| Net income including noncontrolling interests | 2,313 | (271 | ) | (61 | ) | 30 | 31 | 2,584 | 2,397 | |||||||||||||||||||
| Net income attributable to Colgate-Palmolive Company | $ | 2,203 | $ | (271 | ) | $ | (61 | ) | $ | 30 | $ | 31 | $ | 2,474 | $ | 2,291 | ||||||||||||
| Earnings per common share 3 | ||||||||||||||||||||||||||||
| Basic | $ | 4.45 | $ | (0.56 | ) | $ | (0.13 | ) | $ | 0.06 | $ | 0.06 | $ | 5.00 | $ | 4.53 | ||||||||||||
| Diluted | $ | 4.31 | $ | (0.53 | ) | $ | (0.12 | ) | $ | 0.06 | $ | 0.06 | $ | 4.84 | $ | 4.37 | ||||||||||||
| 1 |
Includes a $46 pretax gain ($59 aftertax gain, $0.12 diluted earnings per share) related to the remeasurement of the Venezuelan balance sheet and lower taxes on accrued but unpaid remittances resulting from the currency devaluation in January 2010 and a $36 pretax loss ($2 aftertax gain) related to the remeasurement of the Venezuelan balance sheet and lower taxes on accrued but unpaid remittances resulting from the currency devaluation announced in December 2010. |
|
| 2 |
Represents the one-time charge related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. This amount primarily represents the premium paid to acquire U.S. dollar-denominated cash and bonds. Prior to January 1, 2010, these assets had been remeasured at the parallel market rate and then translated for financial reporting purposes at the official rate of 2.15. |
|
| 3 |
Basic and diluted earnings per share are computed independently for each quarter and the year to date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for the year to date period. In addition, the cumulative impact of Non-GAAP adjustments on the basic and diluted earnings per share may not necessarily equal the difference between "As Reported" and "As Adjusted Non-GAAP" as a result of rounding. |
|
|
|
|
Table 5 |
|||||||||
| Colgate-Palmolive Company | |||||||||
| Condensed Consolidated Balance Sheets | |||||||||
|
As of December 31, 2010 and 2009 |
|||||||||
| (Dollars in Millions) (Unaudited) | |||||||||
| December 31, | December 31, | ||||||||
| 2010 | 2009 | ||||||||
| Cash and cash equivalents |
$ |
490 |
$ |
600 | |||||
| Receivables, net | 1,610 | 1,626 | |||||||
| Inventories | 1,222 | 1,209 | |||||||
| Other current assets | 408 | 375 | |||||||
| Property, plant and equipment, net | 3,693 | 3,516 | |||||||
| Other assets, including goodwill and intangibles | 3,749 | 3,808 | |||||||
| Total assets |
$ |
11,172 | $ | 11,134 | |||||
| Total debt | 3,424 | 3,182 | |||||||
| Other current liabilities | 3,119 | 3,238 | |||||||
| Other non-current liabilities | 1,812 | 1,457 | |||||||
| Total liabilities | 8,355 | 7,877 | |||||||
| Total Colgate-Palmolive Company shareholders' equity | 2,675 | 3,116 | |||||||
| Noncontrolling interests | 142 | 141 | |||||||
| Total liabilities and shareholders’ equity |
$ |
11,172 | $ | 11,134 | |||||
| Supplemental Balance Sheet Information | |||||||||
| Debt less cash, cash equivalents and marketable securities* | $ | 2,860 | $ | 2,541 | |||||
| Working capital % of sales | 0.3 | % | (0.4 | %) | |||||
| * |
Marketable securities of $74 and $41 as of December 31, 2010 and 2009, respectively, are included in Other current assets. |
|
|
|
|
Table 6 |
|||||||||||||
|
Colgate-Palmolive Company |
|||||||||||||
|
Condensed Consolidated Statements of Cash Flows |
|||||||||||||
| For the Twelve Months Ended December 31, 2010 and 2009 | |||||||||||||
| (Dollars in Millions) (Unaudited) | |||||||||||||
| 2010 | 2009 | ||||||||||||
| Operating Activities | |||||||||||||
| Net income including noncontrolling interests | $ | 2,313 | $ | 2,397 | |||||||||
|
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: |
|||||||||||||
| Venezuela hyperinflationary transition charge | 271 | - | |||||||||||
| Restructuring, net of cash | - | (18 | ) | ||||||||||
| Depreciation and amortization | 376 | 351 | |||||||||||
| Termination benefits | 86 | - | |||||||||||
| Gain before tax on sale of non-core product lines | (50 | ) | (5 | ) | |||||||||
| Stock-based compensation expense | 121 | 117 | |||||||||||
| Deferred income taxes | 29 | (23 | ) | ||||||||||
| Cash effects of changes in: | |||||||||||||
| Receivables | 40 | 57 | |||||||||||
| Inventories | (10 | ) | 44 | ||||||||||
| Accounts payable and other accruals | (65 | ) | 294 | ||||||||||
| Other non-current assets and liabilities | 100 | 63 | |||||||||||
| Net cash provided by operations | 3,211 | 3,277 | |||||||||||
| Investing Activities | |||||||||||||
| Capital expenditures | (550 | ) | (575 | ) | |||||||||
| Sale of property and non-core product lines | 42 | 17 | |||||||||||
| Purchases of marketable securities and investments | (308 | ) | (289 | ) | |||||||||
| Proceeds from sales of marketable securities and investments | 167 | - | |||||||||||
| Other | (9 | ) | 6 | ||||||||||
| Net cash used in investing activities | (658 | ) | (841 | ) | |||||||||
| Financing Activities | |||||||||||||
| Principal payments on debt | (4,719 | ) | (3,950 | ) | |||||||||
| Proceeds from issuance of debt | 5,015 | 3,424 | |||||||||||
| Dividends paid | (1,142 | ) | (981 | ) | |||||||||
| Purchases of treasury shares | (2,020 | ) | (1,063 | ) | |||||||||
| Proceeds from exercise of stock options and excess tax benefits | 242 | 300 | |||||||||||
| Net cash used in financing activities | (2,624 | ) | (2,270 | ) | |||||||||
| Effect of exchange rate changes on Cash and cash equivalents | (39 | ) | (121 | ) | |||||||||
| Net increase (decrease) in Cash and cash equivalents | (110 | ) | 45 | ||||||||||
| Cash and cash equivalents at beginning of period | 600 | 555 | |||||||||||
| Cash and cash equivalents at end of period | $ | 490 | $ | 600 | |||||||||
| Supplemental Cash Flow Information | |||||||||||||
| Free cash flow before dividends (Net cash provided by operations less capital expenditures) | |||||||||||||
| Net cash provided by operations | $ | 3,211 | $ | 3,277 | |||||||||
| Less: Capital expenditures | (550 | ) | (575 | ) | |||||||||
| Free cash flow before dividends | $ | 2,661 | $ | 2,702 | |||||||||
| Income taxes paid | $ | 1,123 | $ | 1,098 | |||||||||
| Table 7 | ||||||||||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||
| Segment Information | ||||||||||||||||||
| For the Three and Twelve Months Ended December 31, 2010 and 2009 | ||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||
|
Three Months Ended
December 31, |
Twelve Months Ended
December 31, |
|||||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||||
| Net sales | ||||||||||||||||||
| Oral, Personal and Home Care | ||||||||||||||||||
| North America | $ | 731 | $ | 746 | $ | 3,005 | $ | 2,950 | ||||||||||
| Latin America | 1,131 | 1,222 | 4,261 | 4,319 | ||||||||||||||
| Europe/South Pacific | 805 | 865 | 3,220 | 3,271 | ||||||||||||||
| Greater Asia/Africa | 759 | 683 | 2,998 | 2,655 | ||||||||||||||
| Total Oral, Personal and Home Care | 3,426 | 3,516 | 13,484 | 13,195 | ||||||||||||||
| Pet Nutrition | 552 | 565 | 2,080 | 2,132 | ||||||||||||||
| Total Net sales | $ | 3,978 | $ | 4,081 | $ | 15,564 | $ | 15,327 | ||||||||||
|
Three Months Ended
December 31, |
Twelve Months Ended
December 31, |
|||||||||||||||||
| 2010 | 2009 | 2010 | 2009 | |||||||||||||||
| Operating profit | ||||||||||||||||||
| Oral, Personal and Home Care | ||||||||||||||||||
| North America | $ | 216 | $ | 235 | $ | 884 | $ | 843 | ||||||||||
| Latin America 1 | 320 | 373 | 1,295 | 1,360 | ||||||||||||||
| Europe/South Pacific | 170 | 209 | 742 | 748 | ||||||||||||||
| Greater Asia/Africa | 194 | 174 | 767 | 631 | ||||||||||||||
| Total Oral, Personal and Home Care | 900 | 991 | 3,688 | 3,582 | ||||||||||||||
| Pet Nutrition | 146 | 148 | 559 | 555 | ||||||||||||||
| Corporate 2 | (141 | ) | (148 | ) | (758 | ) | (522 | ) | ||||||||||
|
Total Operating profit |
$ | 905 | $ | 991 | $ | 3,489 | $ | 3,615 | ||||||||||
| Note: | The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. | |
| 1 | Latin America Operating profit for the twelve months ended December 31, 2010 includes a $10 pretax gain related to the remeasurement of the Venezuelan balance sheet, including a $46 pretax gain resulting from the currency devaluation on January 8, 2010 and a $36 pretax loss resulting from the announced currency devaluation on December 30, 2010. | |
| 2 |
Corporate operations include stock-based compensation related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. Corporate Operating profit for the twelve months ended December 31, 2010 includes a one-time $271 charge related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010, a fourth quarter $86 pretax charge for termination benefits and a fourth quarter $50 pretax gain on sale of non-core product lines. |
|
|
Table 8 |
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||||||||||||
| Geographic Sales Analysis | ||||||||||||||||||||||||||||||
| Percentage Changes - Fourth Quarter 2010 vs 2009 | ||||||||||||||||||||||||||||||
| December 31, 2010 | ||||||||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||||||
| COMPONENTS OF SALES CHANGE | COMPONENTS OF SALES CHANGE | |||||||||||||||||||||||||||||
| FOURTH QUARTER | TWELVE MONTHS | |||||||||||||||||||||||||||||
| Pricing | Pricing | |||||||||||||||||||||||||||||
| 4th Qtr | Coupons | 12 Months | Coupons | |||||||||||||||||||||||||||
| Sales | 4th Qtr | Consumer & | Sales | 12 Months | Consumer & | |||||||||||||||||||||||||
| Change | Organic | Trade | Change | Organic | Trade | |||||||||||||||||||||||||
|
Region |
As Reported | Sales Change | Volume | Incentives | Exchange | As Reported | Sales Change | Volume | Incentives | Exchange | ||||||||||||||||||||
| Total Company | (2.5 | %) | 1.0 | % | 1.0 | % | 0.0 | % | (3.5 | %) | 1.5 | % | 3.0 | % | 3.0 | % | 0.0 | % | (1.5 | %) | ||||||||||
| Europe/South Pacific | (7.0 | %) | (3.0 | %) | 0.0 | % | (3.0 | %) | (4.0 | %) | (1.5 | %) | (1.0 | %) | 2.0 | % | (3.0 | %) | (0.5 | %) | ||||||||||
| Latin America | (7.5 | %) | 3.5 | % | (1.5 | %) | 5.0 | % | (11.0 | %) | (1.5 | %) | 7.5 | % | 2.0 | % | 5.5 | % | (9.0 | %) | ||||||||||
| Greater Asia/Africa | 11.0 | % | 8.0 | % | 9.0 | % | (1.0 | %) | 3.0 | % | 13.0 | % | 9.0 | % | 10.5 | % | (1.5 | %) | 4.0 | % | ||||||||||
| Total International | (2.5 | %) | 3.0 | % | 2.0 | % | 1.0 | % | (5.5 | %) | 2.5 | % | 5.5 | % | 4.0 | % | 1.5 | % | (3.0 | %) | ||||||||||
| North America | (2.0 | %) | (2.5 | %) | 1.5 | % | (4.0 | %) | 0.5 | % | 2.0 | % | 1.0 | % | 3.5 | % | (2.5 | %) | 1.0 | % | ||||||||||
| Total CP Products | (2.5 | %) | 1.5 | % | 1.5 | % | 0.0 | % | (4.0 | %) | 2.0 | % | 4.0 | % | 4.0 | % | 0.0 | % | (2.0 | %) | ||||||||||
| Hill's | (2.0 | %) | (2.0 | %) | (1.0 | %) | (1.0 | %) | 0.0 | % | (2.5 | %) | (3.5 | %) | (2.0 | %) | (1.5 | %) | 1.0 | % | ||||||||||
|
Table 9 |
||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||||||||||||||||||
| Non-GAAP Effective Tax Rate Reconciliation | ||||||||||||||||||||||||||||||||||||
| For the Three Months Ended December 31, 2010 and 2009 | ||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||||||||||||||||||
| 2010 | 2009 | |||||||||||||||||||||||||||||||||||
|
As Reported |
Venezuela Devaluation - December |
Termination benefits |
Gain on sale of non-core product lines |
Tax initiatives |
As Adjusted Non-GAAP |
As Reported |
||||||||||||||||||||||||||||||
| Income before income taxes | $ | 889 | $ | (36 | ) | $ | (86 | ) | $ | 50 | $ | - | $ | 961 | $ | 973 | ||||||||||||||||||||
| Provision for income taxes | 238 | (38 | ) | (25 | ) | 20 | (31 | ) | 312 | 317 | ||||||||||||||||||||||||||
| Effective tax rate | 26.8 | % | 32.5 | % | 32.6 | % | ||||||||||||||||||||||||||||||
| Non-GAAP Effective Tax Rate Reconciliation | ||||||||||||||||||||||||||||||||||||
| For the Twelve Months Ended December 31, 2010 and 2009 | ||||||||||||||||||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||||||||||||||||||
| 2010 | 2009 | |||||||||||||||||||||||||||||||||||
|
As Reported |
Venezuela Hyperinflationary |
Venezuela Devaluation - January |
Venezuela Devaluation - December |
Termination benefits |
Gain on sale of non-core product lines |
Tax initiatives |
As Adjusted Non-GAAP |
As Reported |
||||||||||||||||||||||||||||
| Income before income taxes | $ | 3,430 | $ | (271 | ) | $ | 46 | $ | (36 | ) | $ | (86 | ) | $ | 50 | $ | - | $ | 3,727 | $ | 3,538 | |||||||||||||||
| Provision for income taxes | 1,117 | - | (13 | ) | (38 | ) | (25 | ) | 20 | (31 | ) | 1,204 | 1,141 | |||||||||||||||||||||||
| Effective tax rate | 32.6 | % | 32.3 | % | 32.2 | % | ||||||||||||||||||||||||||||||